These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 2907593)

  • 21. Diuretic effect of L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, in rats and mice.
    Katsube J; Kato T; Katsuyama M; Maeda Y; Nishikawa S; Nakamura M
    J Pharm Pharmacol; 1986 Jul; 38(7):533-4. PubMed ID: 2875157
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Diuretic effects of L-threo-3,4-dihydroxyphenylserine (L-threo-DOPS) in anesthetized rats.
    Morimoto S; Matsumura Y; Ohyama T; Shinyama H; Ichihara T; Takahashi Y; Hisaki K
    Jpn J Pharmacol; 1990 Mar; 52(3):431-9. PubMed ID: 2110272
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Depressive-like behavior observed with a minimal loss of locus coeruleus (LC) neurons following administration of 6-hydroxydopamine is associated with electrophysiological changes and reversed with precursors of norepinephrine.
    Szot P; Franklin A; Miguelez C; Wang Y; Vidaurrazaga I; Ugedo L; Sikkema C; Wilkinson CW; Raskind MA
    Neuropharmacology; 2016 Feb; 101():76-86. PubMed ID: 26362360
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Studies on the central action of L-threo-3,4-dihydroxyphenyl-serine (L-threo-DOPS) in FLA-63-treated mice.
    Kato T; Katsuyama M; Karai N; Nakamura M; Katsube J
    Pharmacol Biochem Behav; 1987 Feb; 26(2):407-11. PubMed ID: 3106991
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Effect of infused L-threo-3,4-dihydroxyphenylserine on adrenergic activity in patients with familial amyloid polyneuropathy.
    Suzuki T; Higa S; Tsuge I; Sakoda S; Hayashi A; Yamamura Y; Takaba Y; Nakajima A
    Eur J Clin Pharmacol; 1980 Jun; 17(6):429-35. PubMed ID: 6772451
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Microiontophoretic studies on noradrenergic inhibition from locus coeruleus of spinal trigeminal nucleus neurons.
    Sasa M; Fujimoto S; Igarashi S; Munekiyo K; Takaori S
    J Pharmacol Exp Ther; 1979 Sep; 210(3):311-5. PubMed ID: 480182
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Effect of L-threo-3,4-dihydroxyphenylserine(L-threo-DOPS) on brain and serum MHPG levels in mice: evidence for NE formation in CNS.
    Karai N; Kato T; Katsuyama M; Nakamura M; Katsube J
    Life Sci; 1987 Jun; 40(23):2261-8. PubMed ID: 3108598
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excitation by talipexole, a dopamine D2 agonist, of caudate nucleus neurons activated by nigral stimulation.
    Todo N; Momiyama T; Amano T; Kohno Y; Sasa M
    Life Sci; 1994; 54(14):957-66. PubMed ID: 7908115
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of L-erythro-3, 4-dihydroxyphenylserine on sleep-wakefulness patterns and concentrations of brain catecholamines and serotonin in rats.
    Mori M; Hashimoto H; Fukui K; Mori T; Noto T; Nakajima T
    Jpn J Psychiatry Neurol; 1987 Jun; 41(2):301-10. PubMed ID: 3125374
    [TBL] [Abstract][Full Text] [Related]  

  • 30. [Synthesis of norepinephrine from 3,4-dihydroxyphenylserine by L-aromatic amino acid decarboxylase of the rat brain and kidneys].
    Fujiwara H; Inagaki C; Ikeda Y; Tanaka C
    Nihon Yakurigaku Zasshi; 1976 Oct; 72(7):891-8. PubMed ID: 14060
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Electrophysiological effects of the enantiomers of 3-PPP on neurons in the locus coeruleus of the rat.
    Elam M; Clark D; Svensson TH
    Neuropharmacology; 1986 Sep; 25(9):1003-8. PubMed ID: 3774122
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Effect of L-threo-3,4-dihydroxyphenylserine chronic administration on cerebrospinal fluid and plasma free 3-methoxy-4-hydroxy-phenylglycol concentration in patients with Parkinson's disease.
    Yamamoto M; Ogawa N; Ujike H
    J Neurol Sci; 1986 Mar; 73(1):39-44. PubMed ID: 3084714
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effects of L-threo-dihydroxyphenylserine on spinal reflexes and decerebrate rigidity in rats.
    Ono H; Tanabe M; Nakamura T; Nagano N; Fukuda H
    Gen Pharmacol; 1988; 19(3):369-72. PubMed ID: 3138156
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The stereoisomers of 3,4-dihydroxyphenylserine as precursors of norepinephrine.
    Bartholini J; Constantinidis J; Puig M; Tissot R; Pletscher A
    J Pharmacol Exp Ther; 1975 May; 193(2):523-32. PubMed ID: 1142103
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effect of L-threo-3,4-dihydroxyphenylserine on muscle sympathetic nerve activity in humans.
    Iwase S; Mano T; Kunimoto M; Saito M
    J Auton Nerv Syst; 1992 Jun; 39(2):159-67. PubMed ID: 1430796
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Effect of L-threo-3,4-dihydroxyphenylserine (L-DOPS) on catecholamine levels in plasma and cerebrospinal fluid (CSF) in anesthetized rats.
    Ishikawa Y; Kato Y; Murakami Y; Inoue T; Koshiyama H; Imura H
    Proc Soc Exp Biol Med; 1987 Feb; 184(2):197-200. PubMed ID: 3101067
    [TBL] [Abstract][Full Text] [Related]  

  • 37. L-threo-3,4-dihydroxyphenylserine, a noradrenaline precursor, inhibits dopamine release and metabolism in the rat striatum in vivo.
    Mizoguchi K; Tanaka M; Yokoo H; Yoshida M; Tsuda A
    Experientia; 1992 Dec; 48(11-12):1133-4. PubMed ID: 1473578
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Mass spectrometric measurements of norepinephrine synthesis in man from infusion of stable isotope-labelled L-threo-3,4-dihydroxyphenylserine.
    Suzuki T; Sakoda S; Ueji M; Kishimoto S
    Life Sci; 1985 Feb; 36(5):435-42. PubMed ID: 3918223
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The noradrenaline precursor L-DOPS reduces pathology in a mouse model of Alzheimer's disease.
    Kalinin S; Polak PE; Lin SX; Sakharkar AJ; Pandey SC; Feinstein DL
    Neurobiol Aging; 2012 Aug; 33(8):1651-63. PubMed ID: 21705113
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Excitation by dopamine D-2 receptor agonists, bromocriptine and LY 171555, in caudate nucleus neurons activated by nigral stimulation.
    Ohno Y; Sasa M; Takaori S
    Life Sci; 1986 May; 38(20):1867-73. PubMed ID: 2939313
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.